• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE INRATIO 2 PT/INR HOME MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE INRATIO 2 PT/INR HOME MONITOR Back to Search Results
Model Number INRATIO 2
Device Problem Insufficient Information (3190)
Patient Problem Headache (1880)
Event Date 08/03/2016
Event Type  Injury  
Event Description
Alere inr ratio machine testing blood levels extremely thin.Had been using monitor for years then on (b)(6) 2016 levels tested 6.0 and 6.4.Next morning (took warfarin night before) inr was 3.8.I knew immediately something was wrong.I had felt a little lightheaded on (b)(6) 2016 as to why i took reading.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO 2 PT/INR HOME MONITOR
Type of Device
INRATIO 2 PT/INR HOME MONITOR
Manufacturer (Section D)
ALERE
MDR Report Key5972734
MDR Text Key55613881
Report NumberMW5064978
Device Sequence Number1
Product Code GJS
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 09/21/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/21/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberINRATIO 2
Was Device Available for Evaluation? Yes
Type of Device Usage N
Patient Sequence Number1
Treatment
BENTYL AS NEEDED; OTC MEDS: SEE ABOVE. ; RX MEDS: WARFARIN HYDROCHLORTHIAZIDE; SPIRONOLACTONE; VITAMIN B12 INJECTION; VITAMIN D3; XYZAL AS NEEDED; ZOFRAN AS NEEDED
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age41 YR
Patient Weight98
-
-